On July 11, a widely shared WeChat article highlighted the employment challenges faced by individuals recovering from SARS-CoV-2 infection—sparking renewed public concern about post-recovery stigma and discriminatory policies amid ongoing viral circulation.
The issue gained national attention after Foshan Theater issued a formal apology on its Weibo account late that same evening. The theater acknowledged that its prior policy—which barred “individuals who had recovered from confirmed COVID-19 infection”—was overly broad and inconsistent with current public health guidance. Effective the following day, it revised the restriction to apply only to “recovered individuals still within their mandated home health monitoring period.”
According to the theater’s original July 8 WeChat notice outlining entry requirements, Category 6 of prohibited attendees included: “individuals who have recovered from confirmed SARS-CoV-2 infection; asymptomatic individuals who have completed centralized medical observation; and staff members currently undergoing follow-up visits or medical observation.” This language first appeared in an updated policy released on December 22, 2021—and notably expanded upon earlier guidelines by adding a new exclusion criterion: individuals exhibiting any of ten specified symptoms—including fever, dry cough, fatigue, anosmia or ageusia, nasal congestion, rhinorrhea, sore throat, conjunctivitis, myalgia, or diarrhea—within the preceding 48 hours.
The inclusion of recovered individuals in the restricted category likely stemmed from lingering concerns about “viral rebound” (colloquially termed “re-positive” cases)—a phenomenon where PCR tests return positive again after initial recovery. However, such occurrences are now understood to reflect residual non-infectious viral RNA fragments rather than viable, transmissible virus.
This understanding is formally codified in the *Prevention and Control Protocol for Novel Coronavirus Pneumonia (Ninth Edition)*, released by China’s National Health Commission on June 28. The protocol significantly refined management criteria for re-positive cases: individuals with a PCR cycle threshold (Ct) value ≥35—regardless of respiratory symptoms—are no longer subject to isolation, quarantine, or contact tracing measures.
Dr. Jiao Yahui, Director of the Medical Administration and Hospital Management Bureau at China’s National Health Commission, has emphasized that empirical evidence confirms that patients in the convalescent phase with Ct values ≥35 consistently fail to yield replication-competent virus in culture assays—indicating they pose no transmission risk. Similarly, Dr. Hu Biejie, Head of the Department of Infectious Diseases at Zhongshan Hospital and a core member of Shanghai’s expert panel for COVID-19 clinical management, stated unequivocally: “We have observed no secondary infections or community transmission linked to individuals experiencing viral rebound or recurrent positive test results.”